Crossmark

Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink

Crossref DOI link: https://doi.org/10.1186/s12885-018-4947-8

Published Online: 2018-10-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chidwick, Kendal

Strongman, Helen

Matthews, Anthony

Stanway, Susannah

Lyon, Alexander R.

Smeeth, Liam

Bhaskaran, Krishnan
Funding

Funding for this research was provided by:

Wellcome Trust (107731/Z/15/Z)

Royal Society (107731/Z/15/Z)
License Information

Text and Data Mining valid from 2018-10-22
More Information

Article History

Received: 13 March 2018

Accepted: 14 October 2018

First Online: 22 October 2018

Ethics approval and consent to participate

: The protocol for this study was approved by the MHRA Independent Scientific Advisory Committee (ISAC) (protocol number 16_163; protocol included as Additional file : Protocol), and the study was approved by the London School of Hygiene and Tropical Medicine MSc Ethics Committee (approval number 10700). Participant consent is not required for ISAC approved CPRD studies using purely observational data.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.